A number of studies demonstrate the role of Smad4 in pancreatic ductal adenocarcinoma, but only a few studies have explored the roles of inhibitory Smads, Smad6 and Smad7 in this disease (as reviewed by [14]). Here, SMAD6 is linked to pancreatic ductal adenocarcinoma.